Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSS2400054	度拉糖肽注射液	dulaglutide	Injection	Biological Products(3.3)	New Drug Application	2024-05-28		Shandong BoAn Biotechnology Co Ltd			view
CXSS2400051	度拉糖肽注射液	dulaglutide	Injection	Biological Products(3.3)	New Drug Application	2024-05-28		Shandong BoAn Biotechnology Co Ltd			view
CXSS2400053	度拉糖肽注射液	dulaglutide	Injection	Biological Products(3.3)	New Drug Application	2024-05-28		Shandong BoAn Biotechnology Co Ltd			view
CXSS2400052	度拉糖肽注射液	dulaglutide	Injection	Biological Products(3.3)	New Drug Application	2024-05-28		Shandong BoAn Biotechnology Co Ltd			view
JYSZ2300033	度拉糖肽注射液	dulaglutide	Injection	Biological Products	License Renew	2023-08-01					view
JYSZ2300032	度拉糖肽注射液	dulaglutide	Injection	Biological Products	License Renew	2023-08-01					view
JXSS2300005	度拉糖肽注射液	dulaglutide	Injection	Biological Products(3.1)	Import Drug Application	2023-01-11					view
JXSS2300006	度拉糖肽注射液	dulaglutide	Injection	Biological Products(3.1)	Import Drug Application	2023-01-11					view
CXSL2101196	LY05008注射液	dulaglutide	Injection	Biological Products(3.3)	New Drug Application	2021-07-15		Shandong BoAn Biotechnology Co Ltd			view
CXSL2101197	LY05008注射液	dulaglutide	Injection	Biological Products(3.3)	New Drug Application	2021-07-15		Shandong BoAn Biotechnology Co Ltd			view
JYSB2000418	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-08-24	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-09-02	view
JYSB2000419	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-08-24	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-09-02	view
JYSB2000250	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-06-19	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-22	view
JYSB2000251	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-06-19	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Filed	2020-06-22	view
JXSL2000046	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Import Drug Application	2020-05-11	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	In Review	2020-04-30	view
JXSL2000045	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Import Drug Application	2020-05-09	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	In Review	2020-04-30	view
JYSB2000074	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-03-14	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-05-26	view
JYSB2000073	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-03-14	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-05-26	view
JYSB2000050	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-02-19	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-09-27	view
JYSB2000049	度拉糖肽注射液	dulaglutide	Injection	Biological Products	Supplementary Application	2020-02-19	Eli Lilly Nederland B.V.	Eli Lilly Nederland BV	Certificate Issued	2020-09-27	view